Boq Pharmaceuticals-B (02142.HK) spent nearly 9 million Hong Kong dollars to repurchase shares on June 17th.

Information from the Wisdom Finance APP, and Bo Medical-B (02142.HK) announced a plan regarding the repurchase of shares on the market totaling 240 million Hong Kong dollars, considering that the current trading price levels undervalue the company's intrinsic value, business prospects, or recent business achievements. On June 17, 2025, the company repurchased shares on the open market, involving nearly 9 million Hong Kong dollars, which is a significant repurchase amount for a biotechnology company listed on the Hong Kong Stock Exchange in 2025. The acceleration of the repurchase progress reflects the company's commitment to enhancing shareholder value and confidence in the long-term growth prospects of the company. The company may authorize further repurchase plans based on market conditions, but must comply with the applicable repurchase authorization at that time.